Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Anette Kolderup

1PUBLICATIONS

14CO-AUTHORS

Nanomedicine

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Dec 11, 2023

A pan-SARS-CoV-2-specific soluble angiotensin-converting enzyme 2-albumin fusion engineered for enhanced plasma half-life and needle-free mucosal delivery.

Sopisa Benjakul, Aina Karen Anthi, Anette Kolderup

Pageof 1

Frequent Collaborators

1 joint publications

Sopisa Benjakul

1 joint publications

Aina Karen Anthi

1 joint publications

Marina Vaysburd

1 joint publications

Donna Mallery

1 joint publications

Even Fossum

1 joint publications

Anna Albecka

1 joint publications

Aleksandr Ianevski

1 joint publications

Denis Kainov

1 joint publications

Siri Aastedatter Sakya

1 joint publications

Mari Nyquist-Andersen

Frequent Collaborators

1 joint publications

Sopisa Benjakul

1 joint publications

Aina Karen Anthi

1 joint publications

Marina Vaysburd

1 joint publications

Donna Mallery

Top Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

See more related videos

Top Related Videos

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain

Published on : Jul 25, 2022

See more related videos